Orders +9% vs. cons, +11% y-o-y. +30% y-o-y growth in Q2 expected. Soft sales on fewer project deliveries: Q2e to show stronger growth. '22-'26e EPS CAGR of 22%, 25/26 P/E of 15.5x: BUY.
Orders +4% vs cons and up 7% y-o-y. Improvement set to continue. Excellent position in a growing global market. '22-'26e EPS CAGR of 23%: BUY, TP NOK 24 (unch.)
Q3: We are 12-13% below cons on sales and EBITDA. Orders expected at USD 138m, down 11% y-o-y and 9% below cons. '24e EBIT down 5.6%; HOLD, TP NOK 14 (18).